Schildkraut J - Search Results

1

The Association between Mediated Deprivation and Ovarian Cancer Survival among African American Women.

Lawson AB, Kim J, Johnson C, Ratnapradipa KL, Alberg AJ, Akonde M, Hastert T, Bandera EV, Terry P, Mandle H, Cote ML, Bondy M, Marks J, Peres LC, Schildkraut J, Peters ES. Lawson AB, et al. Among authors: schildkraut j. Cancers (Basel). 2023 Oct 4;15(19):4848. doi: 10.3390/cancers15194848. Cancers (Basel). 2023. PMID: 37835542 Free PMC article.

2

High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival.

Lancaster JM, Sayer R, Blanchette C, Calingaert B, Whitaker R, Schildkraut J, Marks J, Berchuck A. Lancaster JM, et al. Among authors: schildkraut j. Clin Cancer Res. 2003 Feb;9(2):762-6. Clin Cancer Res. 2003. PMID: 12576447

3

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, Bentley RC, Berchuck A, Schildkraut JM. Lancaster JM, et al. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):226-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646513 No abstract available.

4

Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.

Wenham RM, Calingaert B, Ali S, McClean K, Whitaker R, Bentley R, Lancaster JM, Schildkraut J, Marks J, Berchuck A. Wenham RM, et al. Among authors: schildkraut j. J Soc Gynecol Investig. 2003 Sep;10(6):381-7. doi: 10.1016/s1071-5576(03)00141-2. J Soc Gynecol Investig. 2003. PMID: 12969782

5

Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.

Wenham RM, Schildkraut JM, McLean K, Calingaert B, Bentley RC, Marks J, Berchuck A. Wenham RM, et al. Among authors: schildkraut jm. Clin Cancer Res. 2003 Oct 1;9(12):4396-403. Clin Cancer Res. 2003. PMID: 14555511

6

Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.

Spillman MA, Schildkraut JM, Halabi S, Moorman P, Calingaert B, Bentley RC, Marks JR, Murphy S, Berchuck A. Spillman MA, et al. Gynecol Oncol. 2005 May;97(2):543-9. doi: 10.1016/j.ygyno.2005.01.025. Gynecol Oncol. 2005. PMID: 15863158

7

Epidemiology of intracranial meningioma.

Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Claus EB, et al. Neurosurgery. 2005 Dec;57(6):1088-95; discussion 1088-95. doi: 10.1227/01.neu.0000188281.91351.b9. Neurosurgery. 2005. PMID: 16331155 Review.

8

Analgesic drug use and risk of ovarian cancer.

Schildkraut JM, Moorman PG, Halabi S, Calingaert B, Marks JR, Berchuck A. Schildkraut JM, et al. Epidemiology. 2006 Jan;17(1):104-7. doi: 10.1097/01.ede.0000190538.55645.f8. Epidemiology. 2006. PMID: 16357602

9

Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.

Schildkraut JM, Moorman PG, Bland AE, Halabi S, Calingaert B, Whitaker R, Lee PS, Elkins-Williams T, Bentley RC, Marks JR, Berchuck A. Schildkraut JM, et al. Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):585-93. doi: 10.1158/1055-9965.EPI-07-0596. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18349276

10

Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.

Hoyo C, Grubber J, Demark-Wahnefried W, Lobaugh B, Jeffreys AS, Grambow SC, Marks JR, Keku TO, Walther PJ, Schildkraut JM. Hoyo C, et al. Among authors: schildkraut jm. J Natl Med Assoc. 2009 Jul;101(7):711-6. doi: 10.1016/s0027-9684(15)30981-0. J Natl Med Assoc. 2009. PMID: 19634593 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters